Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L35 pseudogene 1 (RPL35P1) is a processed pseudogene that shares high sequence similarity with the protein-coding gene ribosomal protein L35 (RPL35), which encodes a structural component of the 60S ribosomal subunit[1][7]. However, RPL35P1 itself does not encode a functional protein. Pseudogenes like RPL35P1 are typically considered non-coding genomic DNA sequences and are not active in cellular protein synthesis or known as therapeutic targets[1][2]. There is no evidence in the scientific literature or gene/protein databases that RPL35P1 serves as a drug target, has biological function, is associated with diseases, or is used as a biomarker[1]. It should not be confused with the functional protein-coding gene RPL35, which is involved in ribosome structure and protein biosynthesis[3][5][9]. RPL35P1 is a non-coding pseudogene without established therapeutic, biological, or biomarker roles and should not be classified as a drug target—any reference to it as such would be incorrect[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L35 pseudogene 1 (RPL35P1).